Supplier
Legacy Good Samaritan Hospital and Medical Center
Legacy Good Samaritan Hospital and Medical Center was paid $18.33M by Medicaid between Jan 2018 and Dec 2024, across 116 billing codes. Its largest line is 99285, emergency room visit (most serious) — 36% of everything it billed.
33Billing provider infoLEGACY GOOD SAMARITAN HOSPITAL AND MEDICAL CENTER
PORTLAND, OR 97210
PORTLAND, OR 97210
33aNPI1780608216assigned 07/27/2006
33bProvider typeDurable Medical Equipment & Medical Supplies
28Total paid$18.33M
24GClaims263,395
24DCodes billed116
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Durable Medical Equipment & Medical Supplies providers in Oregon
Rank by total paid#2 of 239
Median peer was paid$283.90
This provider vs. median64,566×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official JENSEN, SARAH controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 34,094 | $1.60M | |
| 2019 | 35,785 | $2.08M | |
| 2020 | 30,672 | $2.03M | |
| 2021 | 40,020 | $2.77M | |
| 2022 | 48,546 | $3.18M | |
| 2023 | 39,481 | $3.41M | |
| 2024incomplete | 34,797 | $3.26M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 36% | 21,009 | 19,104 | $6.54M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 25% | 19,149 | 17,799 | $4.55M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 17% | 18,429 | 16,946 | $3.06M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 5.0% | 7,699 | 7,144 | $926K |
| 19318 | 3.8% | 152 | 146 | $701K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 3.4% | 11,602 | 10,727 | $621K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 1.9% | 9,315 | 7,898 | $352K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.4% | 3,131 | 2,992 | $260K |
| 92134 | 1.0% | 8,879 | 8,011 | $185K | |
| 19303 | <1% | 39 | 39 | $178K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 2,890 | 2,407 | $140K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,252 | 2,076 | $96K |
104 more codes
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,720 | $71K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 14,443 | $67K |
| 71271 | <1% | 1,261 | $63K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 645 | $53K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,463 | $52K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 394 | $46K |
| 95811 | <1% | 77 | $42K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 825 | $29K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 466 | $25K |
| 71045 | Radiologic examination, chest; single view | <1% | 500 | $22K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 19,095 | $21K |
| 67028 | Intravitreal injection of a pharmacologic agent | <1% | 1,164 | $21K |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | <1% | 40 | $21K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 104 | $21K |
| G0297 | Low dose ct scan (ldct) for lung cancer screening | <1% | 663 | $16K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 142 | $15K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 28 | $15K |
| 92285 | <1% | 469 | $15K | |
| E0601 | Continuous positive airway pressure (cpap) device | <1% | 210 | $14K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 105 | $11K |
| 10061 | <1% | 59 | $10K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 73 | $9K |
| 80053 | Comprehensive metabolic panel | <1% | 21,817 | $6K |
| 92083 | <1% | 119 | $6K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 40,219 | $5K |
| 97542 | <1% | 229 | $5K | |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | <1% | 40 | $4K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 322 | $3K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 495 | $3K |
| 94060 | <1% | 59 | $3K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 95 | $3K |
| 73630 | <1% | 124 | $3K | |
| 97165 | <1% | 26 | $2K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 9,463 | $2K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 47 | $2K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 15 | $1K |
| 97161 | <1% | 24 | $1K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 262 | $1K |
| J3490 | Unclassified drugs | <1% | 2,441 | $1K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 736 | $931.03 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 207 | $869.19 |
| 84484 | <1% | 7,347 | $856.98 | |
| 94799 | <1% | 236 | $805.00 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 157 | $801.22 |
| 73610 | <1% | 14 | $784.89 | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 15 | $617.85 |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 38 | $548.23 |
| 87070 | <1% | 98 | $505.14 | |
| 99441 | <1% | 98 | $468.44 | |
| 92133 | <1% | 24 | $425.52 | |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 88 | $375.60 |
| A4604 | Tubing with integrated heating element for use with positive airway pressure device | <1% | 13 | $351.08 |
| 84703 | <1% | 1,867 | $335.94 | |
| 81001 | <1% | 3,026 | $307.21 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 6,860 | $257.73 |
| J2704 | Injection, propofol, 10 mg | <1% | 2,289 | $231.33 |
| 87631 | <1% | 28 | $218.56 | |
| 97162 | <1% | 13 | $206.86 | |
| A6212 | Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing | <1% | 111 | $192.40 |
| 83690 | <1% | 3,192 | $182.02 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 414 | $162.02 |
| 94726 | <1% | 47 | $160.28 | |
| 83735 | <1% | 762 | $155.61 | |
| 94729 | <1% | 47 | $119.08 | |
| 93308 | <1% | 14 | $117.87 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,692 | $87.43 |
| 80197 | <1% | 223 | $77.79 | |
| 97116 | <1% | 149 | $71.11 | |
| 87799 | <1% | 19 | $64.26 | |
| 87205 | <1% | 24 | $60.44 | |
| 81003 | <1% | 947 | $48.42 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,351 | $41.86 |
| 93321 | <1% | 14 | $34.12 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 569 | $28.00 |
| 83880 | <1% | 190 | $27.00 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 722 | $18.64 |
| A9270 | Non-covered item or service | <1% | 59 | $15.54 |
| J9035 | Injection, bevacizumab, 10 mg | <1% | 28 | $14.71 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 869 | $11.37 |
| 82570 | <1% | 15 | $7.77 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,408 | $7.20 |
| 80069 | <1% | 43 | $6.94 | |
| 81025 | <1% | 111 | $6.89 | |
| 84156 | <1% | 15 | $5.50 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 100 | $5.20 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 548 | $4.80 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 0% | 98 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 856 | $0.00 |
| 87641 | 0% | 77 | $0.00 | |
| J0689 | Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg | 0% | 31 | $0.00 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 0% | 29 | $0.00 |
| C1776 | Joint device (implantable) | 0% | 72 | $0.00 |
| 80299 | 0% | 18 | $0.00 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 30 | $0.00 |
| 36592 | 0% | 30 | $0.00 | |
| L8699 | Prosthetic implant, not otherwise specified | 0% | 52 | $0.00 |
| 82077 | 0% | 507 | $0.00 | |
| V2632 | Posterior chamber intraocular lens | 0% | 95 | $0.00 |
| 36416 | 0% | 54 | $0.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 43 | $0.00 |
| J7999 | Compounded drug, not otherwise classified | 0% | 137 | $0.00 |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 0% | 29 | $0.00 |
| 92567 | 0% | 75 | $0.00 | |
| 85027 | 0% | 36 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialJENSEN, SARAH (VP FINANCE)
| Provider | Location | Paid |
|---|---|---|
| Legacy Emanuel Hospital & Health Center | Portland, OR | $64.24M |
| Legacy Emanuel Hospital & Health Center | Portland, OR | $50.80M |
| Legacy Clinics LLC | Portland, OR | $48.79M |
| Legacy Salmon Creek Hospital | Vancouver, WA | $48.76M |
| Legacy Mount Hood Medical Center | Gresham, OR | $43.16M |
| Silverton Health | Silverton, OR | $29.18M |
| Legacy Emanuel Hospital & Health Center | Portland, OR | $17.03M |
| Legacy Meridian Park Hospital | Tualatin, OR | $13.28M |
| Legacy Salmon Creek Hospital | Vancouver, WA | $9.93M |
| Silverton Health | Silverton, OR | $9.72M |
| Legacy Good Samaritan Hospital and Medical Center | Portland, OR | $3.90M |
| Legacy Meridian Park Hospital | Tualatin, OR | $2.38M |
| Legacy Emanuel Hospital & Health Center | Saint Helens, OR | $1.78M |
| Silverton Health | Silverton, OR | $1.62M |
| Legacy Emanuel Hospital & Health Center | Portland, OR | $1.48M |
| Silverton Health | Mount Angel, OR | $1.18M |
| Legacy Clinics LLC | Sandy, OR | $654K |
| Legacy Emanuel Hospital & Health Center | Saint Helens, OR | $64K |
| Regional Dermatology, LLC | Festus, MO | $38K |
| Legacy Good Samaritan Hospital and Medical Center | Portland, OR | $4K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.